z-logo
open-access-imgOpen Access
Intravitreal bevacizumab (Avastin) in choroidal neovascular membrane in angioid streaks
Author(s) -
Namrita Sachdev,
K. A. Vishwanathan,
Vishali Gupta,
Ramandeep Singh,
Amod Gupta
Publication year - 2007
Publication title -
indian journal of ophthalmology/indian journal of ophthalmology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 51
eISSN - 1998-3689
pISSN - 0301-4738
DOI - 10.4103/0301-4738.36482
Subject(s) - angioid streaks , medicine , bevacizumab , ophthalmology , choroidal neovascularization , macular degeneration , surgery , chemotherapy
Angioid streaks are crack-like dehiscences in the Bruch's membrane, which predispose to the development of a choroidal neovascular membrane (CNVM) that carries a poor visual outcome. We report successful treatment in a 25-year-old woman with bilateral angioid streaks and subfoveal CNVM in the left eye who received two doses of intravitreal bevacizumab (1.25 mg) injections six weeks apart, resulting in rapid regression of the CNVM.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here